Clinical Trial Update: Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating gastrointestinal effects of Mycophenolate mofetil (Myfortic, CellCept) in African American kidney transplant recipients; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: University of Pennsylvania | Conditions: Transplants and Implants | Phase 4 | Status: TERMINATED | Results posted: 2018-01-23